Morning-after pill controversy continues
The U.S. Food and Drug Administration may pose restrictions on proposed over-the-counter sales of the morning-after pill, the Washington Post reports. Also today, an editorial in the New England Journal of Medicine questions whether the agency is being influenced by politics more than science.
Posted by Carla :: 09:56 AM Apr 8
